SalbutaMolIMpurityN;5-[[5-[2-[(1,1-DiMethylethyl)aMino]-1-hydroxyethyl]-2-hydroxyphenyl]Methyl]-α1-[[(1,1-diMethylethyl)aMino]Methyl]-4-hydroxy-1,3-benzenediMethanol;SalbutaMolDiMer;4-(2-(tert-butylamino)-1-hydroxyethyChemicalbookl)-2-(5-(2-(tert-butylamino)-1-hydroxyethyl)-2-hydroxybenzyl)-6-(hydroxymethyl)phenol;SalbutamolEPImpurityN;SalbutamolImpurity13(SalbutamolEPImpurityN);SalbutamolSulfateEPImpurityN;SalbutamolEPImpurityN(AlbuterolDimer)
*The following content is generated by AI and is for reference only.
<h3>Overview</h3>
<p>Salbutamol Impurity L is a critical reference standard for the quality control of the beta-2 adrenergic agonist Salbutamol. It typically arises from <strong>synthetic by-products</strong> during the manufacturing process or via degradation pathways. The compound is characterized by its specific molecular structure, often used to validate HPLC methods in pharmaceutical production.</p>
<h3>Application</h3>
<ul>
<li><strong>Quality Control:</strong> Used as an analytical standard to identify and quantify trace impurities in drug substances.</li>
<li><strong>R&D:</strong> Supports stability studies and method development for respiratory therapeutics.</li>
<li><strong>Regulatory Compliance:</strong> Essential for meeting ICH guidelines regarding impurity profiling in finished inhalation products.</li>
</ul>
<h3>Precautions</h3>
<p>Store under <strong>inert atmosphere</strong> at low temperatures to prevent degradation. Handle with appropriate PPE in a fume hood due to potential sensitization risks. Strictly limit exposure to clinical environments; this material is not for human administration but serves solely as a laboratory reagent.</p>